Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4562571
    • |
  • 21 October, 2023
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pandemic Influenza Vaccine market size was valued at USD 8056.5 million in 2022 and is forecast to a readjusted size of USD 11570 million by 2029 with a CAGR of 5.3% during review period.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
The Global Info Research report includes an overview of the development of the Pandemic Influenza Vaccine industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pandemic Influenza Vaccine.
Regionally, the report analyzes the Pandemic Influenza Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pandemic Influenza Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pandemic Influenza Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pandemic Influenza Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pandemic Influenza Vaccine market.
Regional Analysis: The report involves examining the Pandemic Influenza Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pandemic Influenza Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pandemic Influenza Vaccine:
Company Analysis: Report covers individual Pandemic Influenza Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pandemic Influenza Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).
Technology Analysis: Report covers specific technologies relevant to Pandemic Influenza Vaccine. It assesses the current state, advancements, and potential future developments in Pandemic Influenza Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pandemic Influenza Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pandemic Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pandemic Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pandemic Influenza Vaccine, with price, sales, revenue and global market share of Pandemic Influenza Vaccine from 2018 to 2023.
Chapter 3, the Pandemic Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pandemic Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pandemic Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pandemic Influenza Vaccine.
Chapter 14 and 15, to describe Pandemic Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Pandemic Influenza Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pandemic Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Trivalent Influenza Vaccine
    • 1.3.3 Quadrivalent Influenza Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pandemic Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 6 Months to 3 Years
    • 1.4.3 > 3 Years
  • 1.5 Global Pandemic Influenza Vaccine Market Size & Forecast
    • 1.5.1 Global Pandemic Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Pandemic Influenza Vaccine Sales Quantity (2018-2029)
    • 1.5.3 Global Pandemic Influenza Vaccine Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Pandemic Influenza Vaccine Product and Services
    • 2.1.4 Sanofi Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Pandemic Influenza Vaccine Product and Services
    • 2.2.4 CSL Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 CSL Recent Developments/Updates
  • 2.3 GSK
    • 2.3.1 GSK Details
    • 2.3.2 GSK Major Business
    • 2.3.3 GSK Pandemic Influenza Vaccine Product and Services
    • 2.3.4 GSK Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GSK Recent Developments/Updates
  • 2.4 Viatris
    • 2.4.1 Viatris Details
    • 2.4.2 Viatris Major Business
    • 2.4.3 Viatris Pandemic Influenza Vaccine Product and Services
    • 2.4.4 Viatris Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Viatris Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Pandemic Influenza Vaccine Product and Services
    • 2.5.4 AstraZeneca Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Hualan Bio
    • 2.6.1 Hualan Bio Details
    • 2.6.2 Hualan Bio Major Business
    • 2.6.3 Hualan Bio Pandemic Influenza Vaccine Product and Services
    • 2.6.4 Hualan Bio Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hualan Bio Recent Developments/Updates
  • 2.7 Changchun Institute of Biological
    • 2.7.1 Changchun Institute of Biological Details
    • 2.7.2 Changchun Institute of Biological Major Business
    • 2.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Product and Services
    • 2.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.8 Sinovac
    • 2.8.1 Sinovac Details
    • 2.8.2 Sinovac Major Business
    • 2.8.3 Sinovac Pandemic Influenza Vaccine Product and Services
    • 2.8.4 Sinovac Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sinovac Recent Developments/Updates
  • 2.9 BCHT
    • 2.9.1 BCHT Details
    • 2.9.2 BCHT Major Business
    • 2.9.3 BCHT Pandemic Influenza Vaccine Product and Services
    • 2.9.4 BCHT Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BCHT Recent Developments/Updates
  • 2.10 Jiangsu GDK
    • 2.10.1 Jiangsu GDK Details
    • 2.10.2 Jiangsu GDK Major Business
    • 2.10.3 Jiangsu GDK Pandemic Influenza Vaccine Product and Services
    • 2.10.4 Jiangsu GDK Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jiangsu GDK Recent Developments/Updates
  • 2.11 KM Biologics
    • 2.11.1 KM Biologics Details
    • 2.11.2 KM Biologics Major Business
    • 2.11.3 KM Biologics Pandemic Influenza Vaccine Product and Services
    • 2.11.4 KM Biologics Pandemic Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Pandemic Influenza Vaccine by Manufacturer

  • 3.1 Global Pandemic Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2018-2023)
  • 3.3 Global Pandemic Influenza Vaccine Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Pandemic Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Pandemic Influenza Vaccine Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Pandemic Influenza Vaccine Manufacturer Market Share in 2022
  • 3.5 Pandemic Influenza Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Pandemic Influenza Vaccine Market: Region Footprint
    • 3.5.2 Pandemic Influenza Vaccine Market: Company Product Type Footprint
    • 3.5.3 Pandemic Influenza Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pandemic Influenza Vaccine Market Size by Region
    • 4.1.1 Global Pandemic Influenza Vaccine Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Pandemic Influenza Vaccine Consumption Value by Region (2018-2029)
    • 4.1.3 Global Pandemic Influenza Vaccine Average Price by Region (2018-2029)
  • 4.2 North America Pandemic Influenza Vaccine Consumption Value (2018-2029)
  • 4.3 Europe Pandemic Influenza Vaccine Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Pandemic Influenza Vaccine Consumption Value (2018-2029)
  • 4.5 South America Pandemic Influenza Vaccine Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Pandemic Influenza Vaccine Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 5.2 Global Pandemic Influenza Vaccine Consumption Value by Type (2018-2029)
  • 5.3 Global Pandemic Influenza Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 6.2 Global Pandemic Influenza Vaccine Consumption Value by Application (2018-2029)
  • 6.3 Global Pandemic Influenza Vaccine Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 7.2 North America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 7.3 North America Pandemic Influenza Vaccine Market Size by Country
    • 7.3.1 North America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 8.2 Europe Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 8.3 Europe Pandemic Influenza Vaccine Market Size by Country
    • 8.3.1 Europe Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Pandemic Influenza Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Pandemic Influenza Vaccine Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Pandemic Influenza Vaccine Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 10.2 South America Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 10.3 South America Pandemic Influenza Vaccine Market Size by Country
    • 10.3.1 South America Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Pandemic Influenza Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Pandemic Influenza Vaccine Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Pandemic Influenza Vaccine Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Pandemic Influenza Vaccine Market Drivers
  • 12.2 Pandemic Influenza Vaccine Market Restraints
  • 12.3 Pandemic Influenza Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pandemic Influenza Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pandemic Influenza Vaccine
  • 13.3 Pandemic Influenza Vaccine Production Process
  • 13.4 Pandemic Influenza Vaccine Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pandemic Influenza Vaccine Typical Distributors
  • 14.3 Pandemic Influenza Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pandemic Influenza Vaccine. Industry analysis & Market Report on Pandemic Influenza Vaccine is a syndicated market report, published as Global Pandemic Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pandemic Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,215.52
    		4,823.28
    		6,431.04
    		544,898.40
    		817,347.60
    		1,089,796.80
    		289,849.20
    		434,773.80
    		579,698.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo